We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > AOC

News List

Avidity Biosciences Announces Proposed Public Offering of Common Stock firstwordpharma
August 03, 2021
Avidity Biosciences, Inc. (Nasdaq: RNA) today announced that it intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.
Avidity Biosciences Announces 2021 Pipeline Updates and Research Collaboration with MyoKardia prnewswire
January 11, 2021
Avidity Biosciences, Inc. announced pipeline updates for 2021 and a research collaboration with MyoKardia, Inc., a wholly-owned subsidiary of Bristol Myers Squibb.
Lilly, Avidity Biosciences Enter Global R&D Alliance b3cnewswire
April 23, 2019
Will leverage Avidity's technology platform for the discovery, development and commercialization of potential new medicines in immunology and other indications...